Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 2/20 | 0.32 |
| ▸ | METAP1 | P53582 | 2/20 | 0.32 |
| ▸ | ACP3 | P15309 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820060 | 0.84 | MEN1 (0.33) | — | |
| SCHEMBL4120090 | 0.72 | ROCK2 (0.31) | — | |
| SCHEMBL819082 | 0.72 | KDM4E (0.32) | — | |
| SCHEMBL15388072 | 0.65 | — | — | |
| SCHEMBL818747 | 0.65 | PDE2A (0.38) | PDE2AHSD11B1 | |
| SCHEMBL2384831 | 0.64 | TSHR (0.34) | — | |
| Hydrochloric Acid SCHEMBL919094 | 0.63 | HPGD (0.35) | — | |
| SCHEMBL16426719 | 0.62 | CYP2C9 (0.44) | PDE2AHSD11B1 | |
| SCHEMBL16699727 | 0.62 | BACE1 (0.30) | — | |
| SCHEMBL133552 | 0.62 | BACE1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150038723-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2015-02-05 | — | — | US | disclosed |
| US-8153810-B2 | Alkylidene complexes of ruthenium containing N-heterocyclic carbene ligands; use as highly active, selective catalysts for olefin metathesis | EVONIK DEGUSSA GMBH (DE) | 2012-04-10 | — | — | US | disclosed |
| US-20110282068-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2011-11-17 | — | — | US | disclosed |
| US-20080207911-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2008-08-28 | — | — | US | disclosed |
| US-7378528-B2 | Alkylidene complexes of ruthenium containing N-heterocyclic carbene ligands; use as highly active, selective catalysts for olefin metathesis | EVONIK DEGUSSA GMBH (DE) | 2008-05-27 | — | — | US | disclosed |
| US-20080009598-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | DEGUSSA AG (DE) | 2008-01-10 | — | — | US | disclosed |
| US-7294717-B2 | Alkylidene complexes of ruthenium containing N-heterocyclic carbene ligands; use as highly active, selective catalysts for olefin metathesis | DEGUSSA AG (DE) | 2007-11-13 | — | — | US | disclosed |
| EP-1087838-B1 | ALKYLIDENE COMPLEXES OF RUTHENIUM WITH N-HETEROCYCLIC CARBENE LIGANDS AND THEIR USE AS CATALYSTS FOR OLEFIN METATHESIS | DEGUSSA (DE) | 2005-05-25 | — | — | EP | disclosed |
| US-20050013150-A2 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | Aventis Research @$amp; Technologies GmbH @$amp; Co. KG (DE) | 2005-01-20 | — | — | US | disclosed |
| US-6635768-B1 | Inexpensive, highly active catalysts; high tolerance toward a variety of functional groups but also a wide range of possible variations in the ligand sphere | DEGUSSA AG (DE) | 2003-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282068-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | CBR1, NR2E1, OXER1 | PDE2A 4864/4885METAP2 4316/4885METAP1 4253/4885 |
| US-20150038723-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | OXER1, CBR1, AKR1C4 | PDE2A 4881/4885METAP2 4328/4885METAP1 4384/4885 |
| US-20080207911-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | CBR1, NR2E1, OXER1 | PDE2A 4867/4885METAP2 4265/4885METAP1 4116/4885 |
| US-20080009598-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | CBR1, NR2E1, OXER1 | PDE2A 4867/4885METAP2 4265/4885METAP1 4116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.